Literature DB >> 10837065

Regulatory T cells in autoimmmunity*.

E M Shevach1.   

Abstract

Clonal deletion of autoreactive T cells in the thymus is not the sole mechanism for the induction of tolerance to self-antigens since partial depletion of peripheral CD4(+) T cells from neonatal and adult animals results in the development of organ-specific autoimmunity. Reconstitution of these immunodeficient animals with populations of regulatory CD4(+)T cells prevents the development of autoimmunity. The lineage of regulatory CD4(+) T cells is generated in the thymus and can be distinguished from effector cells by the expression of unique membrane antigens. The target antigens for these suppressor populations and their mechanisms of action remain poorly defined. Depletion of regulatory T cells may be useful in the induction of immunity to weak antigens, such as tumor-specific antigens. Conversely, enhancement of regulatory T cell function may be a useful adjunct to the therapy of autoimmune diseases and for prevention of allograft rejection.

Entities:  

Mesh:

Year:  2000        PMID: 10837065     DOI: 10.1146/annurev.immunol.18.1.423

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  356 in total

Review 1.  Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance.

Authors:  Ralph Marvin Steinman; Michel C Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-02       Impact factor: 11.205

2.  Homeostatic T cell proliferation in a T cell-dendritic cell coculture system.

Authors:  Qing Ge; Deborah Palliser; Herman N Eisen; Jianzhu Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

Review 3.  Transplantation tolerance from a historical perspective.

Authors:  T E Starzl; R M Zinkernagel
Journal:  Nat Rev Immunol       Date:  2001-12       Impact factor: 53.106

Review 4.  T cell homeostasis and systemic autoimmunity.

Authors:  A N Theofilopoulos; W Dummer; D H Kono
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

Review 5.  CD28, CTLA-4 and their ligands: who does what and to whom?

Authors:  D M Sansom
Journal:  Immunology       Date:  2000-10       Impact factor: 7.397

Review 6.  The use of high dose immunoablative therapy with hematopoietic stem cell support therapy in the treatment of severe autoimmune diseases.

Authors:  Alan Tyndall; Alois Gratwohl
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

7.  IL-2 and IL-4 stimulate MEK1 expression and contribute to T cell resistance against suppression by TGF-beta and IL-10 in asthma.

Authors:  Qiaoling Liang; Lei Guo; Shaila Gogate; Zunayet Karim; Arezoo Hanifi; Donald Y Leung; Magdalena M Gorska; Rafeul Alam
Journal:  J Immunol       Date:  2010-10-06       Impact factor: 5.422

8.  Distinct regulation of interleukin-17 in human T helper lymphocytes.

Authors:  Zhi Chen; Cristina M Tato; Linda Muul; Arian Laurence; John J O'Shea
Journal:  Arthritis Rheum       Date:  2007-09

9.  Testing the NKT cell hypothesis of human IDDM pathogenesis.

Authors:  Peter T Lee; Amy Putnam; Kamel Benlagha; Luc Teyton; Peter A Gottlieb; Albert Bendelac
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

10.  Regulatory T cell expansion and immune activation during untreated HIV type 1 infection are associated with disease progression.

Authors:  Weiwei Cao; Beth D Jamieson; Lance E Hultin; Patricia M Hultin; Roger Detels
Journal:  AIDS Res Hum Retroviruses       Date:  2009-02       Impact factor: 2.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.